nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinapril—ACE—vein—colon cancer	0.0806	0.215	CbGeAlD
Quinapril—ACE—umbilical vein—colon cancer	0.0585	0.156	CbGeAlD
Quinapril—ACE—endothelium—colon cancer	0.0277	0.0741	CbGeAlD
Quinapril—ACE—blood vessel—colon cancer	0.0256	0.0684	CbGeAlD
Quinapril—SLC15A1—epithelium—colon cancer	0.0174	0.0464	CbGeAlD
Quinapril—SLC15A1—renal system—colon cancer	0.0161	0.043	CbGeAlD
Quinapril—ACE—embryo—colon cancer	0.0153	0.0408	CbGeAlD
Quinapril—SLC15A1—digestive system—colon cancer	0.0132	0.0353	CbGeAlD
Quinapril—ACE—epithelium—colon cancer	0.0125	0.0333	CbGeAlD
Quinapril—ACE—smooth muscle tissue—colon cancer	0.012	0.0321	CbGeAlD
Quinapril—SLC15A1—vagina—colon cancer	0.0117	0.0312	CbGeAlD
Quinapril—ACE—renal system—colon cancer	0.0116	0.0309	CbGeAlD
Quinapril—SLC15A2—renal system—colon cancer	0.0101	0.0269	CbGeAlD
Quinapril—SLC15A1—liver—colon cancer	0.00985	0.0263	CbGeAlD
Quinapril—ACE—lymphoid tissue—colon cancer	0.00959	0.0256	CbGeAlD
Quinapril—ACE—digestive system—colon cancer	0.00948	0.0253	CbGeAlD
Quinapril—ACE—bone marrow—colon cancer	0.00874	0.0233	CbGeAlD
Quinapril—SLC15A2—vagina—colon cancer	0.0073	0.0195	CbGeAlD
Quinapril—ACE—liver—colon cancer	0.00706	0.0189	CbGeAlD
Quinapril—ACE—lymph node—colon cancer	0.00541	0.0145	CbGeAlD
Quinapril—SLC15A2—lymph node—colon cancer	0.00472	0.0126	CbGeAlD
Quinapril—Renal failure—Irinotecan—colon cancer	0.00372	0.0061	CcSEcCtD
Quinapril—Photosensitivity reaction—Fluorouracil—colon cancer	0.00372	0.00609	CcSEcCtD
Quinapril—Myocardial infarction—Irinotecan—colon cancer	0.00371	0.00609	CcSEcCtD
Quinapril—Haemolytic anaemia—Capecitabine—colon cancer	0.00365	0.00597	CcSEcCtD
Quinapril—Infestation NOS—Fluorouracil—colon cancer	0.00363	0.00595	CcSEcCtD
Quinapril—Infestation—Fluorouracil—colon cancer	0.00363	0.00595	CcSEcCtD
Quinapril—Acute coronary syndrome—Fluorouracil—colon cancer	0.00358	0.00586	CcSEcCtD
Quinapril—Renal failure acute—Capecitabine—colon cancer	0.00356	0.00584	CcSEcCtD
Quinapril—Myocardial infarction—Fluorouracil—colon cancer	0.00356	0.00583	CcSEcCtD
Quinapril—Perindopril—ABCB1—colon cancer	0.00355	0.23	CrCbGaD
Quinapril—Urinary tract infection—Fluorouracil—colon cancer	0.00353	0.00578	CcSEcCtD
Quinapril—Dermatitis exfoliative—Capecitabine—colon cancer	0.00349	0.00572	CcSEcCtD
Quinapril—Urinary tract disorder—Vincristine—colon cancer	0.00345	0.00565	CcSEcCtD
Quinapril—Connective tissue disorder—Vincristine—colon cancer	0.00343	0.00562	CcSEcCtD
Quinapril—Urethral disorder—Vincristine—colon cancer	0.00342	0.00561	CcSEcCtD
Quinapril—Agranulocytosis—Fluorouracil—colon cancer	0.00339	0.00555	CcSEcCtD
Quinapril—Cerebrovascular accident—Capecitabine—colon cancer	0.00336	0.0055	CcSEcCtD
Quinapril—Connective tissue disorder—Irinotecan—colon cancer	0.00334	0.00548	CcSEcCtD
Quinapril—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00329	0.00539	CcSEcCtD
Quinapril—Cardiac disorder—Vincristine—colon cancer	0.00324	0.00531	CcSEcCtD
Quinapril—Pharyngitis—Fluorouracil—colon cancer	0.00323	0.0053	CcSEcCtD
Quinapril—Angiopathy—Vincristine—colon cancer	0.00317	0.00519	CcSEcCtD
Quinapril—Cardiac disorder—Irinotecan—colon cancer	0.00316	0.00517	CcSEcCtD
Quinapril—Mediastinal disorder—Vincristine—colon cancer	0.00315	0.00516	CcSEcCtD
Quinapril—Lisinopril—ABCB1—colon cancer	0.00313	0.202	CrCbGaD
Quinapril—Cilazapril—ABCB1—colon cancer	0.00313	0.202	CrCbGaD
Quinapril—Alopecia—Vincristine—colon cancer	0.00309	0.00506	CcSEcCtD
Quinapril—Angiopathy—Irinotecan—colon cancer	0.00309	0.00506	CcSEcCtD
Quinapril—Immune system disorder—Irinotecan—colon cancer	0.00307	0.00504	CcSEcCtD
Quinapril—Mediastinal disorder—Irinotecan—colon cancer	0.00307	0.00502	CcSEcCtD
Quinapril—Mental disorder—Vincristine—colon cancer	0.00306	0.00501	CcSEcCtD
Quinapril—Arrhythmia—Irinotecan—colon cancer	0.00304	0.00498	CcSEcCtD
Quinapril—Liver function test abnormal—Capecitabine—colon cancer	0.00304	0.00498	CcSEcCtD
Quinapril—Alopecia—Irinotecan—colon cancer	0.00301	0.00493	CcSEcCtD
Quinapril—Orthostatic hypotension—Capecitabine—colon cancer	0.00301	0.00493	CcSEcCtD
Quinapril—Breast disorder—Capecitabine—colon cancer	0.00297	0.00487	CcSEcCtD
Quinapril—Back pain—Vincristine—colon cancer	0.00294	0.00482	CcSEcCtD
Quinapril—Flatulence—Irinotecan—colon cancer	0.00292	0.00478	CcSEcCtD
Quinapril—Arrhythmia—Fluorouracil—colon cancer	0.00291	0.00477	CcSEcCtD
Quinapril—Alopecia—Fluorouracil—colon cancer	0.00288	0.00472	CcSEcCtD
Quinapril—Back pain—Irinotecan—colon cancer	0.00286	0.00469	CcSEcCtD
Quinapril—Sweating increased—Capecitabine—colon cancer	0.00277	0.00454	CcSEcCtD
Quinapril—Angina pectoris—Capecitabine—colon cancer	0.00277	0.00454	CcSEcCtD
Quinapril—Ill-defined disorder—Irinotecan—colon cancer	0.00275	0.0045	CcSEcCtD
Quinapril—Vertigo—Vincristine—colon cancer	0.00273	0.00448	CcSEcCtD
Quinapril—Malaise—Irinotecan—colon cancer	0.00267	0.00438	CcSEcCtD
Quinapril—Vertigo—Irinotecan—colon cancer	0.00266	0.00436	CcSEcCtD
Quinapril—Syncope—Irinotecan—colon cancer	0.00266	0.00435	CcSEcCtD
Quinapril—Renal failure acute—Methotrexate—colon cancer	0.00265	0.00435	CcSEcCtD
Quinapril—Loss of consciousness—Irinotecan—colon cancer	0.0026	0.00427	CcSEcCtD
Quinapril—Dermatitis exfoliative—Methotrexate—colon cancer	0.0026	0.00425	CcSEcCtD
Quinapril—Photosensitivity reaction—Capecitabine—colon cancer	0.0026	0.00425	CcSEcCtD
Quinapril—Myalgia—Vincristine—colon cancer	0.00259	0.00424	CcSEcCtD
Quinapril—Cough—Irinotecan—colon cancer	0.00258	0.00423	CcSEcCtD
Quinapril—Infestation NOS—Capecitabine—colon cancer	0.00254	0.00416	CcSEcCtD
Quinapril—Infestation—Capecitabine—colon cancer	0.00254	0.00416	CcSEcCtD
Quinapril—Anaphylactoid reaction—Methotrexate—colon cancer	0.00253	0.00415	CcSEcCtD
Quinapril—Depression—Capecitabine—colon cancer	0.00253	0.00414	CcSEcCtD
Quinapril—Acute coronary syndrome—Capecitabine—colon cancer	0.0025	0.0041	CcSEcCtD
Quinapril—Cerebrovascular accident—Methotrexate—colon cancer	0.0025	0.0041	CcSEcCtD
Quinapril—Renal failure—Capecitabine—colon cancer	0.00249	0.00409	CcSEcCtD
Quinapril—Discomfort—Irinotecan—colon cancer	0.00249	0.00408	CcSEcCtD
Quinapril—Myocardial infarction—Capecitabine—colon cancer	0.00249	0.00407	CcSEcCtD
Quinapril—Oedema—Vincristine—colon cancer	0.00248	0.00407	CcSEcCtD
Quinapril—Anaphylactic shock—Vincristine—colon cancer	0.00248	0.00407	CcSEcCtD
Quinapril—Infection—Vincristine—colon cancer	0.00247	0.00404	CcSEcCtD
Quinapril—Urinary tract infection—Capecitabine—colon cancer	0.00247	0.00404	CcSEcCtD
Quinapril—Nervous system disorder—Vincristine—colon cancer	0.00243	0.00399	CcSEcCtD
Quinapril—Thrombocytopenia—Vincristine—colon cancer	0.00243	0.00398	CcSEcCtD
Quinapril—Oedema—Irinotecan—colon cancer	0.00242	0.00396	CcSEcCtD
Quinapril—Anaphylactic shock—Irinotecan—colon cancer	0.00242	0.00396	CcSEcCtD
Quinapril—Myalgia—Fluorouracil—colon cancer	0.00241	0.00396	CcSEcCtD
Quinapril—Chest pain—Fluorouracil—colon cancer	0.00241	0.00396	CcSEcCtD
Quinapril—Infection—Irinotecan—colon cancer	0.0024	0.00393	CcSEcCtD
Quinapril—Hyperhidrosis—Vincristine—colon cancer	0.0024	0.00393	CcSEcCtD
Quinapril—Hepatobiliary disease—Capecitabine—colon cancer	0.0024	0.00393	CcSEcCtD
Quinapril—Discomfort—Fluorouracil—colon cancer	0.00239	0.00391	CcSEcCtD
Quinapril—Shock—Irinotecan—colon cancer	0.00238	0.0039	CcSEcCtD
Quinapril—Nervous system disorder—Irinotecan—colon cancer	0.00237	0.00388	CcSEcCtD
Quinapril—Agranulocytosis—Capecitabine—colon cancer	0.00237	0.00388	CcSEcCtD
Quinapril—Thrombocytopenia—Irinotecan—colon cancer	0.00237	0.00388	CcSEcCtD
Quinapril—Hyperhidrosis—Irinotecan—colon cancer	0.00234	0.00383	CcSEcCtD
Quinapril—Oedema—Fluorouracil—colon cancer	0.00231	0.00379	CcSEcCtD
Quinapril—Anaphylactic shock—Fluorouracil—colon cancer	0.00231	0.00379	CcSEcCtD
Quinapril—Infection—Fluorouracil—colon cancer	0.0023	0.00377	CcSEcCtD
Quinapril—Enalapril—ABCB1—colon cancer	0.0023	0.149	CrCbGaD
Quinapril—Hepatitis—Capecitabine—colon cancer	0.00228	0.00373	CcSEcCtD
Quinapril—Nervous system disorder—Fluorouracil—colon cancer	0.00227	0.00372	CcSEcCtD
Quinapril—Thrombocytopenia—Fluorouracil—colon cancer	0.00227	0.00371	CcSEcCtD
Quinapril—Liver function test abnormal—Methotrexate—colon cancer	0.00226	0.00371	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Vincristine—colon cancer	0.00226	0.00371	CcSEcCtD
Quinapril—Pharyngitis—Capecitabine—colon cancer	0.00226	0.0037	CcSEcCtD
Quinapril—Tachycardia—Fluorouracil—colon cancer	0.00226	0.0037	CcSEcCtD
Quinapril—Urinary tract disorder—Capecitabine—colon cancer	0.00225	0.00368	CcSEcCtD
Quinapril—Insomnia—Vincristine—colon cancer	0.00224	0.00368	CcSEcCtD
Quinapril—Connective tissue disorder—Capecitabine—colon cancer	0.00224	0.00367	CcSEcCtD
Quinapril—Urethral disorder—Capecitabine—colon cancer	0.00223	0.00366	CcSEcCtD
Quinapril—Paraesthesia—Vincristine—colon cancer	0.00223	0.00365	CcSEcCtD
Quinapril—Breast disorder—Methotrexate—colon cancer	0.00221	0.00363	CcSEcCtD
Quinapril—Insomnia—Irinotecan—colon cancer	0.00219	0.00358	CcSEcCtD
Quinapril—Paraesthesia—Irinotecan—colon cancer	0.00217	0.00356	CcSEcCtD
Quinapril—Dyspnoea—Irinotecan—colon cancer	0.00215	0.00353	CcSEcCtD
Quinapril—Somnolence—Irinotecan—colon cancer	0.00215	0.00352	CcSEcCtD
Quinapril—Gastrointestinal disorder—Vincristine—colon cancer	0.00214	0.00351	CcSEcCtD
Quinapril—Fatigue—Vincristine—colon cancer	0.00214	0.00351	CcSEcCtD
Quinapril—Eye disorder—Capecitabine—colon cancer	0.00213	0.00349	CcSEcCtD
Quinapril—Dyspepsia—Irinotecan—colon cancer	0.00213	0.00349	CcSEcCtD
Quinapril—Constipation—Vincristine—colon cancer	0.00212	0.00348	CcSEcCtD
Quinapril—Cardiac disorder—Capecitabine—colon cancer	0.00211	0.00346	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00211	0.00346	CcSEcCtD
Quinapril—Insomnia—Fluorouracil—colon cancer	0.00209	0.00343	CcSEcCtD
Quinapril—Gastrointestinal disorder—Irinotecan—colon cancer	0.00209	0.00342	CcSEcCtD
Quinapril—Fatigue—Irinotecan—colon cancer	0.00208	0.00341	CcSEcCtD
Quinapril—Paraesthesia—Fluorouracil—colon cancer	0.00208	0.00341	CcSEcCtD
Quinapril—Pancreatitis—Methotrexate—colon cancer	0.00208	0.0034	CcSEcCtD
Quinapril—Constipation—Irinotecan—colon cancer	0.00207	0.00339	CcSEcCtD
Quinapril—Angiopathy—Capecitabine—colon cancer	0.00207	0.00338	CcSEcCtD
Quinapril—Dyspnoea—Fluorouracil—colon cancer	0.00206	0.00338	CcSEcCtD
Quinapril—Somnolence—Fluorouracil—colon cancer	0.00206	0.00337	CcSEcCtD
Quinapril—Immune system disorder—Capecitabine—colon cancer	0.00206	0.00337	CcSEcCtD
Quinapril—Mediastinal disorder—Capecitabine—colon cancer	0.00205	0.00336	CcSEcCtD
Quinapril—Dyspepsia—Fluorouracil—colon cancer	0.00204	0.00334	CcSEcCtD
Quinapril—Arrhythmia—Capecitabine—colon cancer	0.00203	0.00333	CcSEcCtD
Quinapril—Gastrointestinal pain—Vincristine—colon cancer	0.00203	0.00333	CcSEcCtD
Quinapril—Alopecia—Capecitabine—colon cancer	0.00201	0.0033	CcSEcCtD
Quinapril—Gastrointestinal disorder—Fluorouracil—colon cancer	0.002	0.00327	CcSEcCtD
Quinapril—Mental disorder—Capecitabine—colon cancer	0.00199	0.00327	CcSEcCtD
Quinapril—Feeling abnormal—Irinotecan—colon cancer	0.00199	0.00326	CcSEcCtD
Quinapril—Gastrointestinal pain—Irinotecan—colon cancer	0.00198	0.00324	CcSEcCtD
Quinapril—Abdominal pain—Vincristine—colon cancer	0.00196	0.00321	CcSEcCtD
Quinapril—Flatulence—Capecitabine—colon cancer	0.00195	0.0032	CcSEcCtD
Quinapril—Erectile dysfunction—Methotrexate—colon cancer	0.00195	0.0032	CcSEcCtD
Quinapril—Photosensitivity reaction—Methotrexate—colon cancer	0.00193	0.00317	CcSEcCtD
Quinapril—Back pain—Capecitabine—colon cancer	0.00192	0.00314	CcSEcCtD
Quinapril—Abdominal pain—Irinotecan—colon cancer	0.00191	0.00313	CcSEcCtD
Quinapril—Feeling abnormal—Fluorouracil—colon cancer	0.00191	0.00313	CcSEcCtD
Quinapril—Infestation—Methotrexate—colon cancer	0.00189	0.00309	CcSEcCtD
Quinapril—Infestation NOS—Methotrexate—colon cancer	0.00189	0.00309	CcSEcCtD
Quinapril—Depression—Methotrexate—colon cancer	0.00188	0.00308	CcSEcCtD
Quinapril—Renal failure—Methotrexate—colon cancer	0.00186	0.00304	CcSEcCtD
Quinapril—Propafenone—ABCB1—colon cancer	0.00184	0.119	CrCbGaD
Quinapril—Ill-defined disorder—Capecitabine—colon cancer	0.00184	0.00301	CcSEcCtD
Quinapril—Malaise—Capecitabine—colon cancer	0.00179	0.00293	CcSEcCtD
Quinapril—Hepatobiliary disease—Methotrexate—colon cancer	0.00179	0.00293	CcSEcCtD
Quinapril—Vertigo—Capecitabine—colon cancer	0.00178	0.00292	CcSEcCtD
Quinapril—Asthenia—Vincristine—colon cancer	0.00178	0.00292	CcSEcCtD
Quinapril—Syncope—Capecitabine—colon cancer	0.00178	0.00291	CcSEcCtD
Quinapril—Agranulocytosis—Methotrexate—colon cancer	0.00176	0.00289	CcSEcCtD
Quinapril—Palpitations—Capecitabine—colon cancer	0.00175	0.00287	CcSEcCtD
Quinapril—Loss of consciousness—Capecitabine—colon cancer	0.00174	0.00285	CcSEcCtD
Quinapril—Asthenia—Irinotecan—colon cancer	0.00173	0.00284	CcSEcCtD
Quinapril—Cough—Capecitabine—colon cancer	0.00173	0.00283	CcSEcCtD
Quinapril—Diarrhoea—Vincristine—colon cancer	0.0017	0.00278	CcSEcCtD
Quinapril—Hepatitis—Methotrexate—colon cancer	0.00169	0.00278	CcSEcCtD
Quinapril—Chest pain—Capecitabine—colon cancer	0.00169	0.00277	CcSEcCtD
Quinapril—Myalgia—Capecitabine—colon cancer	0.00169	0.00277	CcSEcCtD
Quinapril—Arthralgia—Capecitabine—colon cancer	0.00169	0.00277	CcSEcCtD
Quinapril—Pharyngitis—Methotrexate—colon cancer	0.00168	0.00276	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00168	0.00275	CcSEcCtD
Quinapril—Urinary tract disorder—Methotrexate—colon cancer	0.00167	0.00274	CcSEcCtD
Quinapril—Discomfort—Capecitabine—colon cancer	0.00167	0.00273	CcSEcCtD
Quinapril—Urethral disorder—Methotrexate—colon cancer	0.00166	0.00272	CcSEcCtD
Quinapril—Diarrhoea—Irinotecan—colon cancer	0.00165	0.00271	CcSEcCtD
Quinapril—Dry mouth—Capecitabine—colon cancer	0.00165	0.0027	CcSEcCtD
Quinapril—Dizziness—Vincristine—colon cancer	0.00164	0.00269	CcSEcCtD
Quinapril—Pruritus—Fluorouracil—colon cancer	0.00164	0.00268	CcSEcCtD
Quinapril—Oedema—Capecitabine—colon cancer	0.00162	0.00265	CcSEcCtD
Quinapril—Infection—Capecitabine—colon cancer	0.00161	0.00263	CcSEcCtD
Quinapril—Dizziness—Irinotecan—colon cancer	0.0016	0.00262	CcSEcCtD
Quinapril—Shock—Capecitabine—colon cancer	0.00159	0.00261	CcSEcCtD
Quinapril—Nervous system disorder—Capecitabine—colon cancer	0.00159	0.0026	CcSEcCtD
Quinapril—Eye disorder—Methotrexate—colon cancer	0.00158	0.0026	CcSEcCtD
Quinapril—Diarrhoea—Fluorouracil—colon cancer	0.00158	0.0026	CcSEcCtD
Quinapril—Thrombocytopenia—Capecitabine—colon cancer	0.00158	0.0026	CcSEcCtD
Quinapril—Tachycardia—Capecitabine—colon cancer	0.00158	0.00259	CcSEcCtD
Quinapril—Vomiting—Vincristine—colon cancer	0.00158	0.00259	CcSEcCtD
Quinapril—Cardiac disorder—Methotrexate—colon cancer	0.00157	0.00258	CcSEcCtD
Quinapril—Skin disorder—Capecitabine—colon cancer	0.00157	0.00257	CcSEcCtD
Quinapril—Rash—Vincristine—colon cancer	0.00156	0.00256	CcSEcCtD
Quinapril—Hyperhidrosis—Capecitabine—colon cancer	0.00156	0.00256	CcSEcCtD
Quinapril—Dermatitis—Vincristine—colon cancer	0.00156	0.00256	CcSEcCtD
Quinapril—Headache—Vincristine—colon cancer	0.00155	0.00255	CcSEcCtD
Quinapril—Angiopathy—Methotrexate—colon cancer	0.00154	0.00252	CcSEcCtD
Quinapril—Vomiting—Irinotecan—colon cancer	0.00154	0.00252	CcSEcCtD
Quinapril—Immune system disorder—Methotrexate—colon cancer	0.00153	0.00251	CcSEcCtD
Quinapril—Dizziness—Fluorouracil—colon cancer	0.00153	0.00251	CcSEcCtD
Quinapril—Mediastinal disorder—Methotrexate—colon cancer	0.00153	0.0025	CcSEcCtD
Quinapril—Rash—Irinotecan—colon cancer	0.00152	0.0025	CcSEcCtD
Quinapril—Dermatitis—Irinotecan—colon cancer	0.00152	0.00249	CcSEcCtD
Quinapril—Headache—Irinotecan—colon cancer	0.00151	0.00248	CcSEcCtD
Quinapril—Fentanyl—ABCB1—colon cancer	0.00151	0.0978	CrCbGaD
Quinapril—Alopecia—Methotrexate—colon cancer	0.0015	0.00245	CcSEcCtD
Quinapril—Mental disorder—Methotrexate—colon cancer	0.00148	0.00243	CcSEcCtD
Quinapril—Nausea—Vincristine—colon cancer	0.00147	0.00242	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00147	0.00241	CcSEcCtD
Quinapril—Vomiting—Fluorouracil—colon cancer	0.00147	0.00241	CcSEcCtD
Quinapril—Insomnia—Capecitabine—colon cancer	0.00146	0.0024	CcSEcCtD
Quinapril—Rash—Fluorouracil—colon cancer	0.00146	0.00239	CcSEcCtD
Quinapril—Dermatitis—Fluorouracil—colon cancer	0.00146	0.00239	CcSEcCtD
Quinapril—Paraesthesia—Capecitabine—colon cancer	0.00145	0.00238	CcSEcCtD
Quinapril—Headache—Fluorouracil—colon cancer	0.00145	0.00238	CcSEcCtD
Quinapril—Dyspnoea—Capecitabine—colon cancer	0.00144	0.00236	CcSEcCtD
Quinapril—Nausea—Irinotecan—colon cancer	0.00144	0.00235	CcSEcCtD
Quinapril—Back pain—Methotrexate—colon cancer	0.00143	0.00234	CcSEcCtD
Quinapril—Dyspepsia—Capecitabine—colon cancer	0.00142	0.00233	CcSEcCtD
Quinapril—Gastrointestinal disorder—Capecitabine—colon cancer	0.0014	0.00229	CcSEcCtD
Quinapril—Fatigue—Capecitabine—colon cancer	0.00139	0.00229	CcSEcCtD
Quinapril—Constipation—Capecitabine—colon cancer	0.00138	0.00227	CcSEcCtD
Quinapril—Nausea—Fluorouracil—colon cancer	0.00137	0.00225	CcSEcCtD
Quinapril—Ill-defined disorder—Methotrexate—colon cancer	0.00137	0.00224	CcSEcCtD
Quinapril—Feeling abnormal—Capecitabine—colon cancer	0.00133	0.00218	CcSEcCtD
Quinapril—Malaise—Methotrexate—colon cancer	0.00133	0.00218	CcSEcCtD
Quinapril—Vertigo—Methotrexate—colon cancer	0.00133	0.00217	CcSEcCtD
Quinapril—Gastrointestinal pain—Capecitabine—colon cancer	0.00132	0.00217	CcSEcCtD
Quinapril—Cough—Methotrexate—colon cancer	0.00129	0.00211	CcSEcCtD
Quinapril—Abdominal pain—Capecitabine—colon cancer	0.00128	0.0021	CcSEcCtD
Quinapril—Arthralgia—Methotrexate—colon cancer	0.00126	0.00206	CcSEcCtD
Quinapril—Myalgia—Methotrexate—colon cancer	0.00126	0.00206	CcSEcCtD
Quinapril—Chest pain—Methotrexate—colon cancer	0.00126	0.00206	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00125	0.00204	CcSEcCtD
Quinapril—Discomfort—Methotrexate—colon cancer	0.00124	0.00203	CcSEcCtD
Quinapril—Anaphylactic shock—Methotrexate—colon cancer	0.0012	0.00197	CcSEcCtD
Quinapril—Infection—Methotrexate—colon cancer	0.0012	0.00196	CcSEcCtD
Quinapril—Nervous system disorder—Methotrexate—colon cancer	0.00118	0.00194	CcSEcCtD
Quinapril—Thrombocytopenia—Methotrexate—colon cancer	0.00118	0.00193	CcSEcCtD
Quinapril—Skin disorder—Methotrexate—colon cancer	0.00117	0.00192	CcSEcCtD
Quinapril—Hyperhidrosis—Methotrexate—colon cancer	0.00116	0.00191	CcSEcCtD
Quinapril—Asthenia—Capecitabine—colon cancer	0.00116	0.0019	CcSEcCtD
Quinapril—Pruritus—Capecitabine—colon cancer	0.00114	0.00188	CcSEcCtD
Quinapril—Diarrhoea—Capecitabine—colon cancer	0.00111	0.00181	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Methotrexate—colon cancer	0.0011	0.0018	CcSEcCtD
Quinapril—Insomnia—Methotrexate—colon cancer	0.00109	0.00178	CcSEcCtD
Quinapril—Paraesthesia—Methotrexate—colon cancer	0.00108	0.00177	CcSEcCtD
Quinapril—Dyspnoea—Methotrexate—colon cancer	0.00107	0.00176	CcSEcCtD
Quinapril—Somnolence—Methotrexate—colon cancer	0.00107	0.00175	CcSEcCtD
Quinapril—Dizziness—Capecitabine—colon cancer	0.00107	0.00175	CcSEcCtD
Quinapril—Dyspepsia—Methotrexate—colon cancer	0.00106	0.00174	CcSEcCtD
Quinapril—Gastrointestinal disorder—Methotrexate—colon cancer	0.00104	0.0017	CcSEcCtD
Quinapril—Fatigue—Methotrexate—colon cancer	0.00104	0.0017	CcSEcCtD
Quinapril—Vomiting—Capecitabine—colon cancer	0.00103	0.00169	CcSEcCtD
Quinapril—Rash—Capecitabine—colon cancer	0.00102	0.00167	CcSEcCtD
Quinapril—Dermatitis—Capecitabine—colon cancer	0.00102	0.00167	CcSEcCtD
Quinapril—Headache—Capecitabine—colon cancer	0.00101	0.00166	CcSEcCtD
Quinapril—Feeling abnormal—Methotrexate—colon cancer	0.000992	0.00163	CcSEcCtD
Quinapril—Gastrointestinal pain—Methotrexate—colon cancer	0.000985	0.00161	CcSEcCtD
Quinapril—Nausea—Capecitabine—colon cancer	0.000961	0.00157	CcSEcCtD
Quinapril—Abdominal pain—Methotrexate—colon cancer	0.000952	0.00156	CcSEcCtD
Quinapril—Asthenia—Methotrexate—colon cancer	0.000864	0.00142	CcSEcCtD
Quinapril—Pruritus—Methotrexate—colon cancer	0.000852	0.0014	CcSEcCtD
Quinapril—Diarrhoea—Methotrexate—colon cancer	0.000824	0.00135	CcSEcCtD
Quinapril—Dizziness—Methotrexate—colon cancer	0.000796	0.0013	CcSEcCtD
Quinapril—Vomiting—Methotrexate—colon cancer	0.000766	0.00125	CcSEcCtD
Quinapril—Rash—Methotrexate—colon cancer	0.000759	0.00124	CcSEcCtD
Quinapril—Dermatitis—Methotrexate—colon cancer	0.000758	0.00124	CcSEcCtD
Quinapril—Headache—Methotrexate—colon cancer	0.000754	0.00124	CcSEcCtD
Quinapril—Nausea—Methotrexate—colon cancer	0.000715	0.00117	CcSEcCtD
